British Society for Rheumatology guideline on management of adult and juvenile onset Sjögren disease

Elizabeth j Price; Stuart Benjamin; Michele Bombardieri; Simon Bowman; Sara Carty; Coziana Ciurtin; Bridget Crampton; Annabel Dawson; Benjamin A Fisher; Ian Giles; Peter Glennon; Monica Gupta; Katie L Hackett; Genevieve Larkin; Wan-Fai Ng; Athimalaipet V Ramanan; Saad Rassam; Saaeha Rauz; Guy Smith; Nurhan Sutcliffe; Anwar Tappuni; Stephen B Walsh

doi:10.1093/rheumatology/keae152

British Society for Rheumatology guideline on management of adult and juvenile onset Sjögren disease

Elizabeth j Price, Stuart Benjamin, Michele Bombardieri, Simon Bowman, Sara Carty, Coziana Ciurtin, Bridget Crampton, Annabel Dawson, Benjamin A Fisher, Ian Giles, Peter Glennon, Monica Gupta, Katie L Hackett, Genevieve Larkin, Wan-Fai Ng, Athimalaipet V Ramanan, Saad Rassam, Saaeha Rauz, Guy Smith, Nurhan SutcliffeAnwar Tappuni, Stephen B Walsh

Inflammation and Ageing

Research output: Contribution to journal › Article › peer-review

117 Downloads (Pure)

Abstract

Sjögren disease (SD) is a chronic, autoimmune disease of unknown aetiology with significant impact on quality of life. Although dryness (sicca) of the eyes and mouth are the classically described features, dryness of other mucosal surfaces and systemic manifestations are common. The key management aim should be to empower the individual to manage their condition-conserving, replacing and stimulating secretions; and preventing damage and suppressing systemic disease activity. This guideline builds on and widens the recommendations developed for the first guideline published in 2017. We have included advice on the management of children and adolescents where appropriate to provide a comprehensive guideline for UK-based rheumatology teams.

Original language	English
Article number	keae152
Journal	Rheumatology (Oxford, England)
Early online date	16 Apr 2024
DOIs	https://doi.org/10.1093/rheumatology/keae152
Publication status	E-pub ahead of print - 16 Apr 2024

Bibliographical note

Access to Document

10.1093/rheumatology/keae152Licence: Creative Commons: Attribution (CC BY)

PriceE2024BritishFinal published version, 3.25 MBLicence: Creative Commons: Attribution (CC BY)

Cite this

Price, E. J., Benjamin, S., Bombardieri, M., Bowman, S., Carty, S., Ciurtin, C., Crampton, B., Dawson, A., Fisher, B. A., Giles, I., Glennon, P., Gupta, M., Hackett, K. L., Larkin, G., Ng, W.-F., Ramanan, A. V., Rassam, S., Rauz, S., Smith, G., ... Walsh, S. B. (2024). British Society for Rheumatology guideline on management of adult and juvenile onset Sjögren disease. Rheumatology (Oxford, England), Article keae152. Advance online publication. https://doi.org/10.1093/rheumatology/keae152

@article{1cb78d5716574a2dbdd66874789d2aaa,

title = "British Society for Rheumatology guideline on management of adult and juvenile onset Sj{\"o}gren disease",

abstract = "Sj{\"o}gren disease (SD) is a chronic, autoimmune disease of unknown aetiology with significant impact on quality of life. Although dryness (sicca) of the eyes and mouth are the classically described features, dryness of other mucosal surfaces and systemic manifestations are common. The key management aim should be to empower the individual to manage their condition-conserving, replacing and stimulating secretions; and preventing damage and suppressing systemic disease activity. This guideline builds on and widens the recommendations developed for the first guideline published in 2017. We have included advice on the management of children and adolescents where appropriate to provide a comprehensive guideline for UK-based rheumatology teams.",

author = "Price, {Elizabeth j} and Stuart Benjamin and Michele Bombardieri and Simon Bowman and Sara Carty and Coziana Ciurtin and Bridget Crampton and Annabel Dawson and Fisher, {Benjamin A} and Ian Giles and Peter Glennon and Monica Gupta and Hackett, {Katie L} and Genevieve Larkin and Wan-Fai Ng and Ramanan, {Athimalaipet V} and Saad Rassam and Saaeha Rauz and Guy Smith and Nurhan Sutcliffe and Anwar Tappuni and Walsh, {Stephen B}",

note = "{\textcopyright} The Author(s) 2024. Published by Oxford University Press on behalf of the British Society for Rheumatology.",

year = "2024",

month = apr,

day = "16",

doi = "10.1093/rheumatology/keae152",

language = "English",

journal = "Rheumatology (Oxford, England)",

issn = "1462-0324",

publisher = "Oxford University Press",

}

Price, EJ, Benjamin, S, Bombardieri, M, Bowman, S, Carty, S, Ciurtin, C, Crampton, B, Dawson, A, Fisher, BA, Giles, I, Glennon, P, Gupta, M, Hackett, KL, Larkin, G, Ng, W-F, Ramanan, AV, Rassam, S, Rauz, S, Smith, G, Sutcliffe, N, Tappuni, A & Walsh, SB 2024, 'British Society for Rheumatology guideline on management of adult and juvenile onset Sjögren disease', Rheumatology (Oxford, England). https://doi.org/10.1093/rheumatology/keae152

TY - JOUR

T1 - British Society for Rheumatology guideline on management of adult and juvenile onset Sjögren disease

AU - Price, Elizabeth j

AU - Benjamin, Stuart

AU - Bombardieri, Michele

AU - Bowman, Simon

AU - Carty, Sara

AU - Ciurtin, Coziana

AU - Crampton, Bridget

AU - Dawson, Annabel

AU - Fisher, Benjamin A

AU - Giles, Ian

AU - Glennon, Peter

AU - Gupta, Monica

AU - Hackett, Katie L

AU - Larkin, Genevieve

AU - Ng, Wan-Fai

AU - Ramanan, Athimalaipet V

AU - Rassam, Saad

AU - Rauz, Saaeha

AU - Smith, Guy

AU - Sutcliffe, Nurhan

AU - Tappuni, Anwar

AU - Walsh, Stephen B

PY - 2024/4/16

Y1 - 2024/4/16

N2 - Sjögren disease (SD) is a chronic, autoimmune disease of unknown aetiology with significant impact on quality of life. Although dryness (sicca) of the eyes and mouth are the classically described features, dryness of other mucosal surfaces and systemic manifestations are common. The key management aim should be to empower the individual to manage their condition-conserving, replacing and stimulating secretions; and preventing damage and suppressing systemic disease activity. This guideline builds on and widens the recommendations developed for the first guideline published in 2017. We have included advice on the management of children and adolescents where appropriate to provide a comprehensive guideline for UK-based rheumatology teams.

AB - Sjögren disease (SD) is a chronic, autoimmune disease of unknown aetiology with significant impact on quality of life. Although dryness (sicca) of the eyes and mouth are the classically described features, dryness of other mucosal surfaces and systemic manifestations are common. The key management aim should be to empower the individual to manage their condition-conserving, replacing and stimulating secretions; and preventing damage and suppressing systemic disease activity. This guideline builds on and widens the recommendations developed for the first guideline published in 2017. We have included advice on the management of children and adolescents where appropriate to provide a comprehensive guideline for UK-based rheumatology teams.

U2 - 10.1093/rheumatology/keae152

DO - 10.1093/rheumatology/keae152

M3 - Article

C2 - 38621708

SN - 1462-0324

JO - Rheumatology (Oxford, England)

JF - Rheumatology (Oxford, England)

M1 - keae152

ER -

British Society for Rheumatology guideline on management of adult and juvenile onset Sjögren disease

Abstract

Bibliographical note

Access to Document

Fingerprint

Cite this